Major Announcements - EVE Energy signed a procurement framework agreement with Smoore International for the continuous supply of battery cells and other products as raw materials, with actual amounts to be determined by future orders [3] - ST Huami's stock is under "double risk" warning due to an audit report expressing inability to provide an opinion for the 2024 financial report, with a recovery of 1.567 billion yuan in occupied funds [4] - Wuzhou Transportation received a regulatory warning for accounting irregularities and failure to fulfill integrity checks for executives, leading to inaccurate financial disclosures [5] - Wenfeng Co. announced that its vice president is under investigation, but this will not significantly impact the company's operations [6] - Fosun Pharma's subsidiary has had its drug included in the breakthrough therapy designation program for gastric cancer treatment, marking a significant development in its product pipeline [7][8] - Shandong Steel's subsidiary is applying for bankruptcy liquidation, which is expected to increase the parent company's net profit by 15.88 million yuan [9] - Zhouming Technology established a new subsidiary, Shenzhen Zhixian Robotics Co., with a registered capital of 50 million yuan [10] Share Buybacks and Holdings - Spring Airlines conducted its first share buyback, acquiring 35,800 shares for a total of 1.9997 million yuan [11] - Donghua Software's controlling shareholder reduced his stake by 1%, selling 10.9832 million shares [12] - Changshu Bank's executives plan to increase their holdings by at least 550,000 shares over the next six months [13] Major Contracts - Nanfeng Co. won contracts worth 45.7 million yuan and 47.17 million yuan for HVAC systems, with delivery scheduled for 2027 [14] - Huakang Clean announced a pre-bid win for a purification system project at Keqiao Future Medical Center, with a bid price of 176 million yuan [15][16] - Qinglong Pipe Industry secured a contract worth 294 million yuan for a pipe procurement project, expected to impact its performance from 2026 to 2030 [17] - China Nuclear Engineering signed new contracts totaling 123.84 billion yuan as of October, with cumulative revenue of 81.334 billion yuan [18]

Core Viewpoint - The article summarizes important announcements from various companies, providing insights for investors regarding partnerships, financial performance, and regulatory actions. Group 1: Partnerships and Agreements - EVE Energy signed a procurement framework agreement with Smoore International for the continuous supply of battery cells and other products, with the actual amounts to be determined by future orders [4] Group 2: Financial Performance and Risks - ST Huami's stock is under "double risk" warning due to an inability to express an opinion on its 2024 financial report, with 1.567 billion yuan of occupied funds recovered [5] - Shandong Steel's subsidiary Metallurgical Ecology is applying for bankruptcy liquidation, which is expected to increase the parent company's net profit by 158.8 million yuan [9] Group 3: Regulatory Actions - Wuzhou Transportation received a regulatory warning for accounting irregularities and failure to fulfill integrity checks for executives, leading to inaccurate financial disclosures [6] - Wenkang's vice president is under investigation, but the company states that this will not significantly impact its operations [7] Group 4: New Projects and Contracts - Nanfeng Co. won contracts worth 45.7 million yuan and 47.17 million yuan for HVAC systems, expected to positively impact future financial performance [14] - Huakang Clean announced a pre-bid win for a purification system project at Keqiao Future Medical Center, with a bid of 176 million yuan [16] - Qinglong Pipe Industry secured a contract worth 294 million yuan for pipe procurement, which represents 10.43% of its audited revenue for 2024 [17] - China Nuclear Engineering signed new contracts totaling 123.84 billion yuan as of October 2025, with revenue of 81.334 billion yuan [18] Group 5: Share Buybacks and Holdings - Spring Airlines conducted its first share buyback, acquiring 35,800 shares for a total of 1.9997 million yuan [11] - Donghua Software's controlling shareholder reduced his stake by 1%, now holding 10.90% of the company [12] - Changshu Bank's executives plan to increase their holdings by at least 550,000 shares over the next six months [13]

Group 1: Pharmaceutical Developments - Fosun Pharma's subsidiary has received breakthrough therapy designation for its PD-1 monoclonal antibody, Surulintinib, for gastric cancer treatment, marking a significant milestone as no other PD-1 targeted monoclonal antibody has been approved for this indication globally [1] - Surulintinib is already approved in China, the EU, and the UK for various cancers, including non-small cell lung cancer and esophageal squamous cell carcinoma [1] Group 2: Supply Agreements - EVE Energy has signed a procurement framework agreement with Simor International for battery cell supplies from 2026 to 2028, although the agreement does not specify financial amounts [1] - The actual financial impact will depend on future orders and will not significantly affect the company's performance in 2025 [1] Group 3: Corporate Actions - Huarong Chemical has not yet introduced clients in the photolithography or photolithography machine sectors, focusing instead on potassium hydroxide and chlorine products for semiconductor and photovoltaic applications [2] - Xunji Technology plans to transfer certain PCB manufacturing assets to its wholly-owned subsidiary and will inject 49.9 million yuan into the subsidiary to support its operations [3] - TuoJing Technology's major shareholder plans to reduce its stake by up to 3% through block trading, with a reduction period set from December 2025 to March 2026 [4] Group 4: Market Activities - Moer Thread has announced a public offering of 70 million shares at a price of 114.28 yuan per share, aiming to raise approximately 8 billion yuan, with a net amount expected to be around 7.576 billion yuan after expenses [5] - Hefu China has experienced a significant stock price increase, with a cumulative rise of 291.92% over a short period, leading to potential market volatility and a possible request for trading suspension [6]

Group 1 - Moer Thread announced an issuance price of 114.28 CNY per share, with a total of 70 million shares to be publicly issued, aiming to raise 8 billion CNY, netting approximately 7.576 billion CNY after expenses [1] - EVE Energy signed a procurement framework agreement with Simo International for battery cells from 2026 to 2028, with the agreement effective until December 31, 2028, but does not specify a concrete amount [1] - Tuojing Technology's major shareholder, the National Integrated Circuit Industry Investment Fund, plans to reduce its stake by up to 3% through block trading from December 12, 2025, to March 11, 2026 [1] Group 2 - Shengyi Electronics announced that its shareholder, Dongguan Science and Technology Innovation Investment Group, plans to reduce its stake by up to 1% from December 12, 2025, to March 11, 2026, due to funding needs [2] - Deep Technology reported that it is a leading domestic high-end storage chip packaging and testing company, currently operating at full capacity in Shenzhen and Hefei, and is expanding based on customer demand [2] - Wengfeng Co. announced that its deputy general manager, Qin Guofen, is under investigation, but this matter is personal and will not significantly impact the company's operations [2] Group 3 - Fosun Pharma's subsidiary, Shanghai Fuhong Hanlin Biotechnology, has had its drug, Surulitinib, included in the breakthrough therapy designation for gastric cancer, with no other PD-1 monoclonal antibody approved for this indication globally [3] - Daye Co. is responding to the EU's anti-dumping investigation on Chinese lawnmowers, adjusting its overseas production structure and integrating resources to mitigate impacts [4]

Core Viewpoint - EVE Energy has signed a framework procurement agreement with Smoore International for the continuous supply of battery cells and related products, indicating a strategic partnership aimed at stabilizing supply chains and enhancing operational efficiency [1][2]. Group 1: Agreement Details - The agreement will commence from January 1, 2026, to December 31, 2028, focusing on the procurement of battery cells and other products, with costs determined based on market standards and previous contracts [2]. - The agreement is classified as a related party transaction due to the involvement of EVE Energy's board member in Smoore International, ensuring compliance with regulatory requirements [1][2]. Group 2: Financial Impact - The agreement does not specify transaction amounts, thus it is not expected to significantly impact EVE Energy's financial performance for 2025, with future impacts dependent on actual orders [2]. - EVE Energy anticipates a maximum of 6.592 billion yuan in daily related transactions with various affiliated parties in 2026, with 2.21 billion yuan already recorded in the first ten months of the year [2]. Group 3: Company Performance - For the first three quarters of 2023, EVE Energy reported total revenue of 45 billion yuan, a year-on-year increase of 32.17%, and a net profit attributable to shareholders of 2.816 billion yuan, reflecting an 18.40% growth [3]. - The company achieved a significant increase in battery shipments, with a 66.98% year-on-year growth in power battery shipments and a 35.51% increase in energy storage battery shipments [3]. Group 4: Future Outlook - EVE Energy expects continued growth in energy storage sales and improved gross margins in the fourth quarter, with a target for overseas energy storage battery shipments to exceed 25% in the coming year [4]. - The company is also focusing on the development of solid-state batteries and plans to enhance production capabilities through minor investments in existing production lines [5].

Resumption of Trading - Strait Innovation's stock trading suspension has been completed, and it will resume trading on November 21, 2025 [1] Mergers and Acquisitions - Qianying High-Tech: Zhongzhong Group plans to make a tender offer to acquire 20% of shares at a price of 11.85 yuan per share [2] - Dongfang Yuhong: A wholly-owned subsidiary intends to acquire 60% equity of Brazil's Novakem for 144 million yuan, expanding into the Latin American market [3] Share Buybacks and Increases - Aidi Precision plans to repurchase shares worth 100 million to 200 million yuan, with a repurchase price not exceeding 27 yuan per share [4] - Hangcai Co. plans to repurchase shares worth 50 million to 100 million yuan, with a repurchase price not exceeding 80 yuan per share [5] - Feiwo Technology's controlling shareholder plans to increase holdings of the company's shares by 40 million to 70 million yuan [6] External Investments and Daily Operations - Yiwei Lithium Energy has signed a procurement framework agreement for battery cells with Smoore International for the years 2026-2028 [7] - Nanfeng Co. received a bid notification from China General Nuclear Power Engineering, with bid amounts of 45.7 million yuan and 47.17 million yuan [8] - Fosun Pharma's subsidiary has had a drug included in the breakthrough therapy designation program, marking the first monoclonal antibody targeting PD-1 approved for gastric cancer neoadjuvant/adjuvant therapy globally [8] - Longhua New Materials has completed the construction and production of a project with an annual capacity of 330,000 tons of polyether polyol [8] - Lek Electric plans to transfer 90% equity of its wholly-owned subsidiary Precision Machinery for 235 million yuan [9] - Yingboer has officially become a supplier for VOLOCOPTER, providing development services for the electric propulsion system of the XPro aircraft [10] - Shandong Steel's controlling subsidiary plans to apply for bankruptcy liquidation, expecting an increase in profit of 15.88 million yuan [11] - Zhouming Technology has established a controlling subsidiary, Zhixian Robotics [12] - Huakang Clean has pre-qualified for the purification system project at Keqiao Future Medical Center, with a bid price of 176 million yuan [13] - China Nuclear Construction has achieved new contracts totaling 123.84 billion yuan as of October [13]

Core Points - The procurement framework agreement between Smoore International (06969) and EVE Energy (300014) established on November 4, 2022, will expire on December 31, 2025 [1] - A new procurement framework agreement has been signed between Smoore International and EVE Energy on November 20, 2025, for the supply of battery products [1] - The new agreement will be effective from January 1, 2026, to December 31, 2028, ensuring a reliable supply of battery products for Smoore International [1] - EVE Energy is recognized as a long-term reliable supplier with a good reputation for meeting quality standards required by Smoore International and its customers [1]

Core Viewpoint - Smoore International (06969) has entered into a new procurement framework agreement with EVE Energy, which will take effect from January 1, 2026, and will last until December 31, 2028, following the expiration of the previous agreement on December 31, 2025 [1] Group 1 - The previous procurement framework agreement between Smoore International and EVE Energy was established on November 4, 2022, and will expire on December 31, 2025 [1] - The new agreement signifies a continued partnership, with EVE Energy recognized as a long-term reliable supplier of battery products for Smoore International [1] - EVE Energy's battery products are noted for their good reputation and ability to meet the quality standards required by Smoore International and its customers [1]

香 港 交 易 及結 算 所 有 限 公 司 及 香港 聯 合 交 易 所 有 限 公司 對 本 公 告 之 內 容 概不 負 責 ， 對 其 準 確 性 或 完 整性 亦 不 發 表 任 何 聲 明， 並 明 確 表 示 ， 概 不對 因 本 公 告 全 部 或 任何 部 分 內 容 而 產 生或因倚賴該等內容而引致之任何損失承擔任何責任。 採購框架協議將於2025年12月31日失效。有鑑於此，本公司欣然宣佈，本公 司已與億緯鋰能訂立新採購框架協議。 （ 於開曼群島註冊成立的有限公司） （股份代號：6969） 重續持續關連交易 重續持續關連交易 茲提述本公司（ 為其本身及代表其附屬公司（） 作為客戶 ）與億緯鋰能（ 為其本 身及代表其附屬公司（）作為供應商 ）所訂立日期為2022年11月4日的採購框架 協 議 ， 據 此 ， 億 緯 鋰 能 集 團 將 為 本 集 團 製 造 電 池 產 品 。 詳 情 請 參 閱 本 公 司 2024年年報第36至37頁「持續關連交易」一節。 Smoore International Holdings Limited 思 摩 爾 國 際 控 股 有 限 公 司 新採購框架 ...

Group 1 - Company Yiwei Lithium Energy signed a procurement framework agreement with Simor International on November 20, 2025, for the continuous supply of battery cells and other products as raw materials, with actual amounts to be determined by future orders [1] - ST Huamei's stock is under "double risk" warning due to an inability to express an opinion in its 2024 financial report, with a recovery of 1.567 billion yuan in occupied funds as of August 15, 2025, and the stock remains under risk warning with a 5% trading limit [2] - Wuzhou Transportation received a regulatory warning from the Shanghai Stock Exchange for non-compliance in accounting practices and failure to fulfill integrity checks for executives, requiring a rectification report [3] Group 2 - Wenkang Co.'s deputy general manager Qin Guofen is under investigation, but the company states this will not significantly impact its operations [4] - Fosun Pharma's subsidiary Shanghai Fuhong Hanlin's drug, SLR-121, has been included in the breakthrough therapy designation for gastric cancer treatment, marking a significant milestone as no PD-1 monoclonal antibody has been approved for this indication globally [5] - Shandong Steel's subsidiary plans to apply for bankruptcy liquidation, which is expected to increase the parent company's net profit by 15.88 million yuan, allowing the company to focus on its core business [6] Group 3 - Zhuhai Ming Technology established a new subsidiary, Shenzhen Zhixian Robotics Co., with a registered capital of 50 million yuan, in which Zhuhai Ming holds a 50% stake [7] - Spring Airlines conducted its first share buyback, repurchasing 35,800 shares for a total of 1.9997 million yuan, representing 0.0037% of its total share capital [9] - Donghua Software's controlling shareholder reduced his stake by 1%, bringing his direct holding down to 10.90%, in line with a previously disclosed plan [11] Group 4 - Changshu Bank's executives plan to increase their holdings by at least 550,000 shares over the next six months, with specific minimum amounts for each executive [12] - Nanfeng Co. won contracts worth 45.7 million yuan and 47.17 million yuan for HVAC systems, with delivery dates set for July and August 2027, respectively [14] - Huakang Clean's bid for the Keqiao Future Medical Center purification system project was successful, with a bid amount of 176 million yuan [15] - Qinglong Pipe Industry secured a contract worth 294 million yuan for a pipe procurement project, expected to impact its performance from 2026 to 2030 [16] - China Nuclear Engineering signed new contracts totaling 123.84 billion yuan and achieved revenue of 81.334 billion yuan as of October 2025 [17]